Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. - Wikidata - awgldk - TriplyDB

Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats.

Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats.

http://www.wikidata.org/entity/Q46410862

about

Mitochondria in the diabetic heart PPARs and the cardiovascular system How exercise may amend metabolic disturbances in diabetic cardiomyopathy Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock Effects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle?Cardiac remodeling in obesity.Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism.Carbohydrate-enriched diet impairs cardiac performance by decreasing the utilization of fatty acid and glucose.Improvement of mechanical heart function by trimetazidine in db/db mice.An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart.Taking pressure off the heart: the ins and outs of atrophic remodelling.Updating experimental models of diabetic cardiomyopathy Bariatric surgery to unload the stressed heart: a metabolic hypothesis Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice.Pioglitazone attenuates acute cocaine toxicity in rat isolated heart: potential protection by metabolic modulation.Tracing cardiac metabolism in vivo: one substrate at a time.Nonischemic heart failure in diabetes mellitus.Heart in diabetes: not only a macrovascular disease.Metabolic reserve of the heart: the forgotten link between contraction and coronary flow.Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy.Histopathological Evaluation of Heart Toxicity of a Novel Selective PPAR-γ Agonists CKD-501 in db/db Mice Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography.Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation.Effect of isoflurane on myocardial energetic and oxidative stress in cardiac muscle from Zucker diabetic fatty rat.Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart.Metabolic adaptation follows contractile dysfunction in the heart of obese Zucker rats fed a high-fat "Western" diet.In vivo metabolic phenotyping of myocardial substrate metabolism in rodents: differential efficacy of metformin and rosiglitazone monotherapy.Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle.Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.Myocardial ischemic-reperfusion injury in a rat model of metabolic syndrome.Myocardial and metabolic dysfunction in type 2 diabetic rats: impact of ghrelin.Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor.Early diabetes treatment does not prevent sympathetic dysinnervation in the streptozotocin diabetic rat heart.

P2860

Q24633336-96BA62D2-AB25-4416-B2BF-6854814A60C6 Q24642728-1C8BCD9D-A337-437F-81BA-BC3B7F2355AF Q26863272-ECD1F070-CD42-42D6-9E7C-79F816704946 Q28276371-CC36045F-E567-4319-9495-4080C710E4FE Q28575608-2B58F176-0966-42EF-903C-048FD523CCEC Q30353176-FA697AB9-42B7-41A6-9C2E-D82AAF9A34EE Q34043589-6D998C28-6809-445B-8AEE-9F7DDFFD7EC2 Q34150535-39FDB689-7215-44AF-A053-F4E021F463AF Q34161720-0C1F28F0-8A21-48B3-A228-87F22880DE73 Q34193904-88A5A0EC-9FDA-4873-ABEE-D6860E7FFD6C Q34305220-42800072-2CD8-479C-99D3-C7837A06364B Q35045905-5D0D2D79-CC07-45CD-B850-E263BEA935B7 Q35564129-4B594D08-9D74-46E7-9404-E4EBB4E1D90E Q35900971-039A5395-2915-4A34-AA55-85C99E09C3A3 Q35970883-9C1F7582-10FA-44A6-B460-66FFE178249E Q36172303-EE6378F0-3C57-4F2B-9B60-4F49A0CC84EB Q36726181-8323DE7F-BA46-443C-88E1-7C817CA7CEAF Q36762969-CF941A1E-45FF-4C7D-869A-2E773C0FB66F Q36783718-C7762B52-F03D-4C46-A89C-8C38031DC3BE Q36821021-532E9CAC-FD32-4483-8E01-680BCCD3C2A8 Q36844816-7B2A6779-2E00-455E-B88D-D37D242213F3 Q37145560-C0D7A4AB-EFAC-4413-8D80-A6E4061CEEF4 Q37293974-0BF788E2-1988-4428-B315-08F01102C49A Q37458369-93EE6576-5656-466B-B954-A6408FD81949 Q37514842-0195A22B-F8E3-421D-93A0-2D476B8A7835 Q37663364-1C4DE145-DF04-4D6F-B99F-968BFDB91086 Q38187952-65D090BC-BAC2-4A1E-A71E-261AE06C5B64 Q39782499-2F4409D7-2441-4702-B072-6A4FB32CE339 Q41832683-BC8AB37D-639F-4F12-82A7-292D9F9F0E16 Q42737141-DD48E832-F18B-4522-8FD2-DCD118835C4B Q46015949-7E63CC48-3812-4278-A9EB-C191C437E662 Q46417053-2E51CEAB-6F01-41CC-8B1B-A59DDD079969 Q46451239-1CA29789-F059-4540-8F6B-B64865A4F050 Q47768315-40FDB47C-8823-47C3-833D-CA9328692D56 Q53063989-69D40781-18E8-43F8-9C15-EAC3A41FDFA7

P2860

Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats.

http://www.wikidata.org/entity/Q46410862

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Activation of PPARgamma enhanc ...... ed working hearts of ZDF rats.

@en

Activation of PPARgamma enhanc ...... ed working hearts of ZDF rats.

@nl

type

label

Activation of PPARgamma enhanc ...... ed working hearts of ZDF rats.

@en

Activation of PPARgamma enhanc ...... ed working hearts of ZDF rats.

@nl

prefLabel

Activation of PPARgamma enhanc ...... ed working hearts of ZDF rats.

@en

Activation of PPARgamma enhanc ...... ed working hearts of ZDF rats.

@nl

P1433

Q46410862-69EED808-E33B-4EDA-BC9A-6FB43D4F10AE

P1476

Q46410862-EB495F23-C09E-49B6-B745-76DD8FDAD45D

P2093

Q46410862-07F7B65B-594C-4441-B61B-6E28A2A8A114

Q46410862-1301F67E-3FA8-431C-AA22-324B83570144

Q46410862-48B35A7F-B75B-42DB-8A63-F43123B30497

Q46410862-71C18791-4487-41D1-9633-85EB694F59F5

Q46410862-867921E1-E39D-41F3-B7DF-E7A4E786DAE2

Q46410862-AC2A2EC1-F2E5-434A-A914-2463F6B126F3

Q46410862-BA707134-DB8A-4E2D-8BD8-91617E9CE127

Q46410862-BE476513-EE11-4B00-8E33-1FEB04B51BD6

Q46410862-E3D6DB29-3909-4C2A-A3B7-3ECD7B171BF8

Q46410862-EE08A20D-6234-4D1A-B919-2BD5D66D9161

P2860

Q46410862-08FC22AF-06E1-46D1-909F-FEC950BC1249

Q46410862-143F2F1E-DF73-4508-B7D7-7B53C188D923

Q46410862-17200FF4-7410-45D6-893F-0000FE94D7EA

Q46410862-18C780BC-95D9-491E-85C7-C9BE2A3A0B4C

Q46410862-27969582-4A3C-4FFB-931F-DF81A3EFA1C3

Q46410862-3607097E-C71C-4D7C-A274-EF7E939A3D0B

Q46410862-392B7ED5-0BAB-412C-94F6-074FB0924591

Q46410862-3A47BB37-02CF-44FA-868E-C260E29BE754

Q46410862-4020F00A-64F1-4F99-B284-4A33E830FCF8

Q46410862-40A5B6EF-E80B-4AB4-B65F-654C1A1C23E5

P304

Q46410862-DC718156-91F4-4AE8-9247-8BBBD8403192

P31

Q46410862-9962338E-A940-4ED1-BA43-6457E962E640

P356

Q46410862-6EA8C503-5D2F-4594-95E2-152B685A721B

P433

Q46410862-4BCE6671-E9C8-43D1-9789-7304851A0ACF

P478

Q46410862-97CF1E42-8B4E-4C97-ADAD-077601A26716

P577

Q46410862-256E25A6-BA08-49C5-94BD-31C37F5BA777

P698

Q46410862-ABC68D09-1A8D-48EE-AA69-12300C8C3568

P356

AJPENDO.00055.2005

P1433

American Journal of Physiology - Endocrinology and Metabolism

P1476

Activation of PPARgamma enhanc ...... ed working hearts of ZDF rats.

@en

P2093

Christopher R Wilson

http://www.w3.org/2001/XMLSchema#string

Heinrich Taegtmeyer

http://www.w3.org/2001/XMLSchema#string

Julia V Adrogue

http://www.w3.org/2001/XMLSchema#string

Kathleen K Brown

http://www.w3.org/2001/XMLSchema#string

Leonard S Golfman

http://www.w3.org/2001/XMLSchema#string

Martin E Young

http://www.w3.org/2001/XMLSchema#string

Mathias Burgmaier

http://www.w3.org/2001/XMLSchema#string

Melissa Van Arsdall

http://www.w3.org/2001/XMLSchema#string

Patrick H Guthrie

http://www.w3.org/2001/XMLSchema#string

Saumya Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of cloned ATP-sensitive potassium channel activation by oleoyl-CoA

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat

Starvation and diabetes reduce the amount of pyruvate dehydrogenase phosphatase in rat heart and kidney

PPARs and the complex journey to obesity

Fuel selection in human skeletal muscle in insulin resistance: a reexamination.

A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content.

Adaptation and maladaptation of the heart in diabetes: Part I: general concepts.

Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression

Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle.

The diabetic heart: metabolic causes for the development of a cardiomyopathy.

P304

E328-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPENDO.00055.2005

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

289

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15797988

http://www.w3.org/2001/XMLSchema#string